These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39412702)

  • 1. First-in-human study of D6-[
    Zhao R; Chen J; Ye T; Chu J; Li J; Zhang Y; Xu S; Liu S; Chen L; Ploessl K; Alexoff D; Kung HF; Zhu L; Wang X
    EJNMMI Radiopharm Chem; 2024 Oct; 9(1):71. PubMed ID: 39412702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT
    PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VMAT2 imaging agent, D6-[
    Zhao R; Zha Z; Yao X; Ploessl K; Choi SR; Liu F; Zhu L; Kung HF
    Nucl Med Biol; 2019; 72-73():26-35. PubMed ID: 31330409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of VMAT2 with the Novel Radioligand [
    Nag S; Jahan M; Tóth M; Nakao R; Varrone A; Halldin C
    ACS Chem Neurosci; 2021 Dec; 12(24):4580-4586. PubMed ID: 34813272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [
    Zhao C; Liu C; Tang J; Xu Y; Xie M; Chen Z
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
    Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent.
    Lin KJ; Weng YH; Wey SP; Hsiao IT; Lu CS; Skovronsky D; Chang HP; Kung MP; Yen TC
    J Nucl Med; 2010 Sep; 51(9):1480-5. PubMed ID: 20720042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molar activity of [
    Liu C; Tang J; Xu Y; Cao S; Fang Y; Zhao C; Chen Z
    J Pharm Biomed Anal; 2021 Sep; 203():114212. PubMed ID: 34153939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
    Chen Z; Tang J; Liu C; Li X; Huang H; Xu X; Yu H
    Nucl Med Biol; 2016 Jan; 43(1):124-129. PubMed ID: 26526872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of striatal
    Liu XL; Liu SY; Barret O; Tamagnan GD; Qiao HW; Song TB; Lu J; Chan P
    Front Aging Neurosci; 2022; 14():931015. PubMed ID: 35936768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Weng CC; Huang SL; Chen ZA; Lin KJ; Hsiao IT; Yen TC; Kung MP; Wey SP; Hsu CH
    Ann Nucl Med; 2017 Aug; 31(7):506-513. PubMed ID: 28451991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
    Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
    Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
    Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.